Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

NCT02684578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration
Macular Degeneration, Age-Related
Dry Macular Degeneration
Geographic Atrophy

Interventions

DRUG: Metformin

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]